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This review paper brings an overview of the use of chitosans in nanostructured films produced with the
Langmuir-Blodgett (LB) or the electrostatic layer-by-layer (LbL) techniques, with emphasis on their possible
applications. From a survey in the literature one may identify three main types of study with chitosan in
nanostructured films. First, the interaction between chitosans and phospholipid Langmuir monolayers has been
investigated for probing the mechanisms of chitosan action in their biological applications, with the monolayers
serving as cell membrane models. In the second type, chitosan serves as a matrix for immobilization of biomolecules
in LB as well as in LbL films, for which chitosan is suitable to help preserve the bioactivity of such biomolecules
for long periods of time even in dry, solid films. An important application of these chitosan-containing films is
in sensing and biosensing. The third type of study involves exploiting the mechanical and biocompatibility properties
of chitosan in producing films with enhanced properties, for example, for tissue engineering. It is emphasized
that chitosans have been proven excellent building blocks to produce films with controlled molecular architecture,
allowing for synergy between distinct materials. We also discuss the prospects of the field, following a critical
review of the latest developments in nanostructured chitosan films.
1. Introduction
The increasing importance of materials from renewable
sources has put chitosans in the spotlight, especially due to their
biological properties, which have been exploited in many
applications.1,2 Chitosan is a biopolymer found as structural
material in some fungi, but it is mainly obtained from the
deacetylation of chitin extracted from shells of crustacean and
mollusks such as shrimps, crabs, and squids. Chitin is produced
in the amount of one hundred billion tons per year in nature,
but its practical use is severely limited by its insolubility, in
contrast to its derivative chitosan.3,4 Because the deacetylation
of chitin hardly proceeds completely in normal heterogeneous
reactions, chitosans are actually random copolymers with
acetylated and deacetylated 2-deoxy-D-glucopyranose units
joined by  (1f4) links. The structures of chitin and chitosan
are given in Figure 1.
The most distinguishing chitosan properties are its biodegrad-
ability and biocompatibility, which makes it a green polymer.
Being biocompatible in this context means that chitosan can
interact with biomolecules without degrading them. Also
important is that chitosan is the only positively charged, naturally
occurring polysaccharide,5 for chitosan may then interact
strongly with negatively charged entities, including many lipids
and proteins. This is advantageous in several of the applications
envisaged, such as in transfection, where stable complexes
between chitosan and DNA fragments can be formed.6-8 With
regard to LbL films, the cationic nature of chitosan is exploited
in distinct architectures with polyanions, as will be extensively
discussed in this review.
Among the various uses of chitosans, of special relevance
have been the biologically related applications, for chitosan was
found able to promote tissue regeneration, which is used in tissue
engineering, wound healing and implants.9,10 Chitosan formula-
tions are exploited in drug delivery, where chitosan in various
forms, for example, nanoparticles, microparticles, and fibers,
is the vehicle for delivering drugs.2 Chitosan is also used as an
antimicrobial agent11,12 to avoid bacterial growth or kill
microorganisms, in actions explained in terms of disruption of
the cell membrane and penetration of chitosan with disturbance
of the cell functions. Another characteristic of chitosan is its
suitability as a matrix for immobilizing enzymes,13,14 where the
enzyme activity is preserved in a solid film probably because
chitosan retains a considerable amount of bound water mol-
ecules. Examples of such nanostructured films containing
enzymes will be detailed in section 3.2.1.1.
This paper is organized as follows. After an introduction to
nanostructured films in section 2, section 3 brings a survey of
Langmuir monolayers, LB and LbL films made with chitosans.
In addition to grouping the contributions of the literature into
three main classes, a critical review is provided for some of the
work presented in the literature. For some of the papers identified
in the survey as relevant, we restricted ourselves to a succinct
description in order to be as comprehensive as possible in
covering the subject without turning the review excessively long.
The main challenges and opportunities for the near future in
this field are discussed in section 4.
2. Nanostructured Films
Nanostructured films can be built in a way that parameters
such as thickness, composition, morphology, surface density,
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Figure 1. Chemical structure of chitin and chitosan (in its protonated
form).
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and roughness are accurately controlled. In many cases, these
properties are manipulated at the molecular level, with inter-
molecular interactions investigated in detail. The approaches
employed to produce such films include the Langmuir,
Langmuir-Blodgett, and the layer-by-layer techniques.
A Langmuir monolayer is formed on liquid surfaces, usually
at the air-water interface, when amphiphilic, insoluble mol-
ecules are spread through a solution of organic, volatile solvents.
After solvent evaporation, the hydrophobic moieties of the
compound spread are directed toward the air, while the
hydrophilic ones are anchored to the aqueous subphase. These
films can attain several degrees of packing depending on the
molecular surface density, usually determined by measuring the
surface tension. The decrease in surface tension caused by the
presence of the interfacial film, from γo for the pure aqueous
(or pure water) subphase to the tension γ in the presence of the
monolayer, is referred to as surface pressure (π; where
π ) γo - γ). A Langmuir film may then be characterized by
measuring π as a function of the average area per molecule
(A), which is varied by action of lateral barriers, thus yielding
π-A isotherms. The surface compressional modulus (Cs-1:
calculated from π-A isotherms with the equation: Cs-1 )
-A ·dπ/dA) is used to determine the physical states of the
monolayer. Analogous to a 3D system, one may define gaseous,
liquid-expanded, liquid-condensed, and solid phases for Lang-
muir monolayers, even including first- and second-order transi-
tions in some cases. The breakdown of the monolayer structure,
denoted by a decrease or stabilization of π at high surface
pressures, is called collapse, being attributed to the formation
of multilayers or vesicles as the monolayer is compressed
beyond its limits in terms of molecular packing.
In addition to the surface pressure isotherms, other methods
have been used to characterize Langmuir films, including surface
potential measurements, Brewster angle microscopy, fluores-
cence microscopy, and optical spectroscopy.15-17 Though the
study and fabrication of Langmuir films is normally aimed at
optimizing conditions for the deposition of Langmuir-Blodgett
(LB) films (see below), a Langmuir monolayer is itself useful
for investigation of intermolecular interactions, especially in
mimicking biointerfaces, such as half of cell membranes,
digestive droplets, and biological tissues.
The pioneering work on liquid monolayers by Irving Lang-
muir in 191718 was complemented by Katharine B. Blodgett in
1934,19 who transferred the films from the liquid surface onto
solid supports. This was performed by dipping or removing a
solid support from the aqueous subphase that intercepted
vertically the monolayer, in a process that can be repeated to
produce a multilayer film. The transfer of the monolayer takes
place at a constant surface pressure, which needs to be
sufficiently high, with an equally high Cs-1, for restoring the
initial value of π that tends to decrease as molecules are removed
from the interface to be transferred. The films on the solid
support are the so-called Langmuir-Blodgett (LB) films, for
which many potential applications have been suggested.
The architecture of Langmuir and LB films is depicted in
Figure 2A, with different phases in the π-A isotherms and the
idealized molecule organization shown in Figure 2B.
LbL films are formed with the spontaneous adsorption of
charged molecules in an aqueous solution, in alternating layers
of oppositely charged molecules.20 Adsorption is ionic and does
not involve covalent bonding. In addition to the ionic interaction,
secondary forces, including H-bonding, may be responsible for
Figure 2. (A) Schematic architecture of Langmuir and LB films for an ideal amphiphilic molecule; the types of LB films that can be formed are
also shown. (B) Illustration of the relative order of the molecules at the air-water interface and its correspondence with the different phases of
the π-A isotherm for the phospholipid dipalmitoyl phosphatidyl choline (DPPC). Aex indicates the extrapolated area of the condensed phase,
which roughly matches the cross section area occupied by each molecule. LE: liquid-expanded, LC: liquid-condensed.
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the adsorption of LbL films,21,22 and therefore, a large number
of molecules can be used in film formation. These include
polyelectrolytes,23 functionalized nanoparticles24 and nano-
tubes,25 phthalocyanines,26 and biomolecules.27 An equally wide
variety of applications have been suggested for the LbL films,
such as sensors,28 membranes,29 nanocapsules,30 liposomes,31
and new materials for tissue engineering.32 The typical structure
for LbL films is shown in Figure 3.
3. Chitosan-Containing Nanostructured Thin Films
3.1. Chitosan-Containing Langmuir and LB Films. Be-
cause chitosan is not soluble in organic solvents, its processing
as Langmuir and LB films is feasible only if chemical
modifications are performed in its structure. Reports have
appeared in the literature where chitosan derivatives were
employed, as discussed in subsection 3.1.1. Besides chemical
modifications, another strategy for the incorporation of water-
soluble biomacromolecules at the air-water interface is their
adsorption from the water subphase, which is the topic in
subsection 3.1.2.
3.1.1. Langmuir and LB Films of Chemically Modified
Chitosans. To our knowledge, the first report of a Langmuir
film made of derivatives of chitosan appeared in 1993,33 with
chitosan incorporating long alkyl chains attached to the primary
OH and amine groups. These chitosan derivatives were soluble
in chloroform and formed stable, condensed monolayers. Also,
LB films up to 20 layers could be deposited, whose layer
thickness was about 2 nm, consistent with the calculated size
of the alkyl chain plus the size of the polymer backbone. The
aim of their work was to apply the films in drug delivery systems
and chiral devices.
Miyashita and co-workers described the synthesis and pro-
cessing as LB films of derivatives of chitosan pentamers.34,35
A series of N,N-dialkyl derivatives were produced through the
reductive amination using ethyl, butyl, heptyl, or lauryl aldehyde,
and sodium borohydride. The low molecular weight and reduced
interchain hydrogen bond, promoted by the insertion of the
lateral alkyl groups, made the products soluble in chloroform,
and thus, Langmuir films could be spread on an aqueous
subphase.34 The area per molecule, extrapolated to zero surface
pressure for the condensed phase, was consistent with the size
of the glucopyranose ring of chitosan, around 50-60 Å2.36 The
film stability decreased when the pH of the subphase lowered,
due to the higher water solubility of the chitosan derivative.
Y-type LB films with up to 60 layers could be transferred onto
quartz substrates. The films were smooth and had 1.74 nm per
layer, according to X-ray diffraction (XRD) data.
The same group extended the work to other amphiphilic
chitosans, namely, N,N-dialkyl-chitosans of molecular weight
ranging from 3 to 10 kDa of various chain lengths.37,38 The
Langmuir films exhibited similar behavior to the pentamers, with
condensed, stable films. The main goal was to produce vesicles
from the modified polymers, which were used in drug release
trials. As a general trend, the rate of drug release was slower
for vesicles made of high molecular weight chitosans and longer
alkyl groups as side chains. The efficiency of drug release of
the vesicles could also be related to the profile of the surface
pressure isotherms. In general, the higher the compressibility
modulus of the Langmuir film (Cs-1, calculated from the π-A
isotherms) the slower was the release rate from the vesicles of
vitamin B12 (model drug). This relationship is shown in Figures
4 and 5, where the maximum compressibility modulus increased
for the products according to the order a1 < b1 < c1 < a2 < b2 <
c2 (Figure 4), and the inverse trend (decreasing in the same order
of samples) is observed for the release rate (Figure 5). As a
vesicle is formed by one or multiple bilayers of lipids, which
have a similar structure to a Langmuir monolayer, the cor-
respondence of Figures 4 and 5 is an interesting example of
how vesicle properties can be predicted upon studying Langmuir
monolayers. This correspondence is expected because mono-
layers with high Cs-1 are more rigid, and therefore, vesicles
made with such membranes should be a more difficult barrier
for the drug to pass. Chitosan samples represented with the
subindex “1” were produced from a 3 kDa starting material,
Figure 3. Typical structure of an LbL film made from polyelectro-
lytes.
Figure 4. Compressibility modulus calculated from π-A isotherms
of N,N-dialkyl chitosans with different side groups and chain length
(see text). Reprinted with permission from ref 38. Copyright 2007
Elsevier.
Figure 5. Drug release kinetics for self-assembled vesicles formed
from the same N,N-dialkyl chitosans used in the experiments of Figure
4. Reprinted with permission from ref 38. Copyright 2007 Elsevier.
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while those with the subindex “2” were obtained with a 10 kDa
chitosan. The letters a, b, and c indicate the substitution with
octyl, decyl, and dodecyl groups, respectively.
Wu Y. and co-workers synthesized amphiphilic chitosans with
an alkyl group combined with a cinnamoyl chromophore to
facilitate the optical characterization of the LB films.39 Through
amine protection with a methanesulfonic counterion combined
with a two-step synthesis, a chitosan could be modified with
octanoyl moieties at both hydroxyl groups and cinnamoyl units
at the amine group. This derivative was named octanoylchitosan
cinnamate, for which the Langmuir film displayed a low collapse
pressure of 25 mN/m and a limiting area of 100 Å2. This large
area, twice the value expected for the glucopyranose ring, was
attributed to the hindering of packing imposed by the cinnamate
side groups, which have restricted mobility. LB films of this
derivative were deposited onto hydrophobic quartz plates at 10
mN/m. Because the transfer ratios during the downstroke were
only 0.6, while they were close to 1.0 in the upstrokes, the films
were considered the XY-type, as they possess an intermediate
structure between X- and Y-type LB films depicted in Figure
2A. The main feature of the deposited LB films was the chirality
arising from the chitosan backbone helices, which was preserved
in the compressed monolayer. Indeed, in contrast to drop-cast
films or solutions, the circular dichroism signal pointed to a
uniaxial orientation of the polymer chains.
Mixed films were obtained with cholesterol and another
chloroform-soluble derivative of chitosan, namely, O,O-di-
palmitoyl chitosan.40 This derivative formed nonmonomolecular
Langmuir films whose surface pressure isotherms depended on
the volume of solution spread. When mixed with cholesterol,
the isotherms had a well-defined collapse pressure, but the
miscibility was not ideal for any proportion of cholesterol. The
neat films of the chitosan derivative could be transferred from
the air-water interface to gold plate substrates, and the LB film
homogeneity was confirmed by Fourier-transformed infrared
spectroscopy (FTIR). The O,O-substituted chitosan could be
cross-linked with glutaraldehyde, thus, forming a polymer gel
employed in removing cholesterol from THF-water solutions.
Tong et al.40 showed that 20 mg/mL of the chitosan derivative
gel in solution could recover up to 33% of the cholesterol
initially dissolved (initial concentration of 1.5 mmol L-1). This
binding to cholesterol was not observed for unmodified chitosan
or chitin samples, being ascribed to dispersive interactions
between the alkylic palmitoyl chains and the sterol. The authors
then suggested that this chitosan derivative may be used in
sequestering cholesterol from foods.
3.1.2. Langmuir and LB Films Formed by Chitosan
Adsorption from the Subphase. Many water-soluble biomacro-
mocules exhibit a surface excess, thus, forming Gibbs mono-
layers at the air-water interface. (A Gibbs monolayer at the
air/water interface is formed by a soluble material that comes
from the bulk of the subphase.) For instance, the hydrophobic
and hydrophilic amino acid residues in polypeptide structures
confer surface activity to proteins. However, Gibbs monolayers
are not normally formed with chitosan owing to its very limited
surface activity that depends on the molecular weight, pH, and
degree of acetylation (DA). To overcome the poor surface
activity, one can form a Gibbs or a Langmuir monolayer at the
air-water interface of a compound that promotes the chitosan
interaction. The film may be made with polymers or typical
amphiphilic molecules, but in most cases, biologically relevant
molecules are used, including phospholipids and cholesterol,
as they not only promote chitosan adsorption, but also serve as
biomembrane models.
3.1.2.1. Adsorption of Chitosan to a Bare Air-Water
Interface. Chitosan in acidic aqueous solutions is supposed
to remain soluble and does not present any surface activity,
analogous to typical polyelectrolytes. Schulz et al.41 studied
the emulsification properties of chitosan and stated that
chitosan was not surface active for the air/water interface,
but had non-negligible activity for oil-water interfaces from
which its emulsifier properties arose. The lack of surface
activity of chitosan in diluted solutions was also discussed
by Babak and co-workers,42 while studying complexes of
chitosan and carboxymethyl-chitin with the surfactants
sodium dodecyl sulfate (SDS) and tetradecyltrimethylam-
monium bromide (TDAB). The surfactant efficiency, that is,
the ability to induce a decrease in surface tension, was higher
for the complex than for the pure surfactants in solution at
the same concentration, which was attributed to the formation
of ionic pairs at the interface. This improved surface activity
was also observed when alkylated chitosan and the surfactants
(SDS and TDAB) were in the solution. But polysoaps with
a degree of substitutions equivalent to the proportion of
surfactant in the complexes (with alkyl chains of the same
size) were less efficient at causing reduction in the surface
tension. The surface activity of a chitosan sample with a
molecular weight of 330 kDa and DA of 10% was almost
nonexistent up to the concentration of 1.6 mg/mL.
The surface activity of alkylated chitosans was enhanced
by increasing the size of the alkyl chains up to 12 carbons,
forming diffusion-dependent Gibbs monolayers.43-49 These
derivatives formed physical gels owing to intermolecular
hydrophobic interactions or hydrogen bonding. The elastic
properties of the Gibbs films were inferred from dynamic
elasticity measurements. After the adsorption of these modi-
fied chitosans at the air-water interface, aggregation occurred
via lateral hydrophobic interactions between covalently bound
alkyl chains and the hydrophobic moieties (acetylamide
groups) of chitosan.
Gargallo et al. used chitosan dissolved in the subphase to
study its effect over a Langmuir monolayer of poly(maleic
anhydride-alt-stearyl methacrylate) (P(MA-alt-StMA).50 The
lift-off area in the surface pressure isotherm increased from 56
to 64 Å2/mol and the collapse pressure decreased from 52 to
31 mN/m with the addition of 3 mg/mL of chitosan in the acetic
acid solution (0.3 mol/L) as the subphase. Such changes in the
surface-pressure-area isotherms were attributed to the migration
of chitosan from the bulk of the solution to the interface. In
contrast to the reports of Babak et al. and Schulz et al.,48,49
Gargallo et al.50 suggested that chitosan is itself surface active
on the basis of surface tension measurements using the de Du
Nou¨y method. Adsorption of chitosan from the solution led to
an increase in surface pressure, which increased with the
chitosan concentration until saturation that occurred at about 5
mg/mL. The maximum increase in pressure (∆π) was 11 mN/m
for subphase temperatures from 10 to 35 °C, while for 45 °C it
was 15 mN/m, as illustrated in Figure 6. Through thermody-
namic calculations, the authors confirmed that the chitosan
adsorption (molecular weight of 161 kDa and DA of 18%) was
spontaneous, with an estimated ∆Gadsorption of -9.9 kJ/mol at
25 °C.
Qun et al.51 measured the surface tension (γ) of several
chitosan samples and correlated the changes in γ with varying
chitosan concentrations with the polymer conformation in
solution. They showed that the surface tension of chitosan
solutions in the range of concentrations between 0 and 4 mg/
mL is the same surface tension of the pure water, and structural
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parameters of the polymer do not have any effect over this
property. However, for chitosan solutions with concentration
above 4 mg/mL the surface tension was affected.
There has been considerable work with chitosans adsorbed
on polymer films at the air/water interface. Mai-ngam52
synthesized a chitosan grafted-copolymer with poly[ethyleneox-
ide] (PEO) and hexyl side chains, where the starting material
was a low molecular weight chitosan chloride (Mw ) 5 kDA).
This chitosan chloride was soluble in water, but the authors
still claimed that it exhibited surface activity.
Pe´pic and co-workers53 used chitosan as an additive in a
triblock-copolymer ((EO)100-(PO)65-(EO)100) solution, then af-
fecting the surface activity and formation of aggregates of the
copolymers in a way that depended on the ionic strength, pH,
temperature, and polymer concentration. In general, the CMC
(critical micellar concentration) and CAC (critical aggregation
concentration) increased with the relative concentration of
chitosan. The authors measured a very small surface activity
for the bare chitosan. The polymer, with molecular weight of
150 kDa and DA of 15.5%, when employed in concentrations
below 0.5 mg/mL, caused a decrease smaller than 2.5 mN/m in
the surface tension of pure water or pure acetate buffer, pH
5.9. Only for chitosan solutions at 0.5 mg/mL in acetate buffer
with pH of 6.4 a shift in γ of 6-7 mN/m was observed. But
this can be attributed to the poor solubility of chitosan in pH
values close to the pKa of the amine groups.
The absence of surface activity for chitosan in very diluted
solutions (concentrations below 0.5 mg/mL) was also stated by
Stenger and coauthors,54 who used chitosan to enhance the
surface activity of pulmonary surfactant aggregates used as a
drug against lung diseases. This increase is caused by the
formation of ion pairs of chitosan-surfactant in solution.
It is concluded that discrepancies exist in the literature with
regard to the surface activity of chitosan. Even though chitosan
behaves as a polyelectrolyte at low pH, which makes it highly
soluble in water, some authors reported the intrinsic tendency
of chitosan to migrate to the surface. The reports on chitosan
surface activity are summarized in Table 1. The reasons why
these discrepancies appear may be that (i) chitosans can exhibit
a variety of structures and compositions, depending on the
molecular weight, DA, and degree of ionization of the amine
group and that (ii) viscous effects for increasingly concentrated
chitosans may affect the surface tension.
3.1.2.2. Adsorption of Chitosan to Preformed Langmuir
and LB Films: Biomembrane Models. In many biological
applications, chitosan interacts with interfaces such as cell
membranes, human tissues, and digestive droplets.2,4,5 A suitable
model to mimic cell membranes is a Langmuir monolayer or
an LB film, as already demonstrated in theoretical and experi-
mental studies.55-57 While liposomes and vesicles can better
mimic the bilayer structure of a cell and allow the study of
transport phenomena, Langmuir monolayers and LB films offer
the advantages of easier control of film composition and state
of packing. Furthermore, with Langmuir and LB films a number
of surface specific techniques can be used to study the molecular
level interactions.
Fang and Chan58 studied the interaction of chitosan with
DPPC bilayers formed onto silica wafers with the fusion of small
unilamellar vesicles. Chitosan was capable of nucleating at the
defects of the lipidic bilayer, forming 33 nm high aggregates
after 1 h of dipping in a 0.025 mg/mL chitosan solution in a
phosphate buffer. For a longer dipping time of 48 h, AFM
images showed that the film had chitosan clusters with 1 µm of
lateral dimension and 56 nm in height. No adsorption of chitosan
was noted on bare mica surfaces. The nucleation of chitosan
clusters in the DPPC bilayer was correlated with the condensing
effect that chitosan had on DPPC Langmuir monolayers when
adsorbed from the subphase. The chitosan used had molecular
weight of 113 kDa and DA of 12.5 and was dissolved in a
subphase in the concentration of 0.008-0.024 mg/mL. The
condensation of the DPPC monolayer increased with the
chitosan concentration.58
The interaction between chitosan and Langmuir monolayers
of cholesterol was studied for a chitosan sample with Mn )
108.7 kDa and DA ) 15%,59 dissolved in an acidic subphase
in the concentration range from 0.050 to 0.300 mg/mL. Chitosan
induced the monolayer to expand, as inferred through surface
pressure and surface potential isotherms and Brewster angle
microscopy (BAM) images. The extent of expansion saturated
at 0.100 mg/mL of chitosan in the subphase. The results were
rationalized by assuming an interaction between specific groups
of chitosan (-NH3+ and -OH) and cholesterol (-OH), mainly
via hydrogen bonds. This hypothesis was also later considered
by other authors.60,61
Parra-Barraza et al.60 used monolayers of stearic acid and
cholesterol as membrane models to interact with four distinct
chitosans: HMW: high molecular weight (Mv ) 267 kDa and
DA ) 16%); MMW: medium molecular weight (Mv ) 102 kDa
and DA ) 22%); chitosan chloride (Mv ) 3.5 kDa and DA )
22%); and HYPM: hydrophobically modified chitosan ) N,N-
dodecyl chitosan (Mv not informed, DS not informed, and DA
) 27%). For the same concentration in the subphase (0.100
mg/mL), all the chitosans caused expansion of cholesterol and
stearic acid Langmuir monolayers. The effects were more
pronounced for cholesterol films, with the largest expansion
induced by HMW that caused a change of 15.9 Å2/mol in the
extrapolated area. HYPM was the only one to induce the
appearance of a liquid-expanded phase in the isotherm of
cholesterol, but all chitosans made the film more compressible,
as measured through the surface compressional modulus (Cs-1).
Interestingly, the degree of expansion for cholesterol monolayers
increased with the concentration of MMW in the subphase, with
no saturation up to 0.300 mg/mL. In contrast, for stearic acid
monolayers the magnitude of expansion was almost the same,
regardless of the MMW concentration. For both amphiphilic
materials, the effects caused by chitosan chloride were smaller
than for the other chitosans, which was attributed to the low
Figure 6. Decrease in surface tension vs concentration of chitosan
in 0.3 M aqueous acetic acid solutions at four different temperatures:
(9) 283 K; (b) 298 K; (2) 308 K; (1) 318 K. Reprinted with permission
from ref 50. Copyright 2004 John Wiley and Sons.
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molecular weight and high solubility of this compound. Some
of the results mentioned are summarized in Table 2.
Langmuir-Blodgett films of cholesterol and stearic acid were
deposited from Langmuir films formed over subphases contain-
ing different chitosans, and characterized by AFM. In contrast
to the work of Fang and Chan,58 MMW-chitosan could be
deposited by dip coating over mica slides, forming a film with
root-mean-square (rms) roughness of 12.3 and 45.6 nm high
aggregates. When deposited together with the lipids, the
chitosans appeared also as aggregates in the film, but in this
case the size of such aggregates was smaller and depended on
the molecular weight. In addition, it was inferred from the AFM
images that the aggregate distribution on the surface was more
homogeneous in films of cholesterol than in the stearic acid
films. For the latter, a higher quantity of isolated domains of
chitosan could be seen. It was then concluded that chitosan
interacts more effectively with cholesterol than with stearic acid.
The author also conducted theoretical calculations to show that
the interaction between chitosan and the sterol occurs via
-NH3+ and -OH groups. For chitosan and deprotonated stearic
acid, this interaction was rather dominated by the electrostatic
binding between -NH3+ and -COO- groups.
The interaction between chitosan and Langmuir monolayers
of cholesterol was also described by Wydro et al.61 Chitosan
caused the cholesterol monolayer to expand, an effect that
increased with chitosan concentration up to saturation. Interest-
ingly, despite the use of a different chitosan sample (Mw ) 330
kDa and DA ) 30%), saturation occurred at 0.100 mg/mL, the
same value reported by Pavinatto et al.59 The monolayer Cs-1
was continuously reduced with the addition of chitosan up to a
concentration of saturation of 0.200 mg/mL. This shows that
the incorporation of chitosan in the film may saturate at 0.100
mg/mL, but the film compressibility is affected up to a higher
chitosan concentration. The effects of chitosan over Langmuir
monolayers of stearic acid (SA) and fatty acids with the same
chain length but distinct degrees of saturation (oleic, linoleic
and R-linoleic) were reported in the same paper. Chitosan also
expanded these films up to a concentration for saturation
between 0.050 (for SA) and 0.100 mg/mL (for linoleic and
R-linoleic acids). The most remarkable feature was the more
effective interaction for the disaturated and trisaturated acids
linoleic and R-linoleic acids. Furthermore, the fact that Cs-1
decreased for SA and increased for all the other fatty acids also
deserves attention. Based on their experiments the authors
proposed that the interaction of chitosan with the studied
materials was initiated by chitosan adsorption to the films,
triggered by electrostatic and hydrogen bond interactions.
Moreover, they speculated that in a second step chitosan
penetrated into the film establishing hydrophobic interactions
with the apolar region of the monolayers.
After the initial work with cholesterol,59 our group in Brazil
started using Langmuir monolayers of the phospholipids DPPC
and dipalmitoyl phosphatidyl glycerol (DPPG), and a chitosan
sample with Mn of 108.7 kDa and DA ) 15%.62 Analogous to
the films of cholesterol, chitosan expanded the phospholipid
monolayers and a concentration of saturation of 0.200 mg/mL
was observed. The surface compressional modulus calculated
from the surface pressure-area isotherms decreased with
chitosan in the subphase. However, the dilatational elasticity
measured with the pendant drop technique showed a dramatic
increase with the incorporation of chitosan, especially for the
negatively charged DPPG. One may understand such different
behavior because Cs-1 is taken from the isotherm obtained in
equilibrium, while the elasticity from drop experiments is
Table 1. Summary of the Results on the Chitosan Surface Activity from the Literature
molecular weight (kDa) DA (%)
concentration
(mg/mL)
∆π
(mN/m) solvent ref
NAa 11 NI negative 1% (v/v) AcOHb 48
330 10 lower than 1.6 0 acetate buffer 0.05 mol/L; pH 4.6 49
161 18 5c 11 0.30 mol/L AcOH 50
5 samples from 80 to 1880 6 or 10 lower than 4 0 0.10 mol/L AcOH 51
1880 10 higher than 5 -13 0.10 mol/L AcOH 51
870 11 lower than 10 0 0.10 mol/L HCl 51
5 3.5 60d 17 pure water 52
150 15.5 lower than 0.5 2.5 acetate buffer 0.05 M; pH 6.5 53
120 20 lower than 0.5 0 saline-HCO3 buffere 54
a NA: not available. b AcOH: acetic acid. c Concentration at which the highest ∆π of 11 mN/m was obtained (temperature 298 K). The surface activity
exponentially increased from 0 to 5 mg/mL, and saturated above this concentration. d CMC measured for chitosan chloride. e Buffer composition: 150 mM
NaCl + 2 mM CaCl2 + 0.2 mM NaHCO3 and pH adjusted to 5.5 with the addition of HCl and NaOH.
Table 2. Features from the π-A Isotherms of Cholesterol with the Different Chitosan Samples Added in the Subphasea (Reproduced from
Ref 60. Copyright 2005 American Chemical Society)
chitosan mixed
with cholesterol chitosan % (w/w) A0 Aex Cs-1 Am
cholesterol 0 44.0 39.6 417 41.6
HYPM 0.01 64.9 48.0 272 46.1
0.02 69.2 55.8 207 51.0
0.03 76.6 61.5 191 52.8
HMW 0.01 58.3 55.5 233 53.1
0.02 60.6 56.9 187 52.7
0.03 71.5 68.9 160 53.5
MMW 0.01 54.0 51.4 282 49.1
0.02 59.8 56.7 202 50.7
0.03 71.2 67.2 133 60.1
chitosan-chloride 0.01 49.5 47.5 255 43.7
0.02 51.5 49.5 229 43.0
0.03 51.5 49.8 254 43.4
a Aex ) extrapolated area; A0 ) area of the “onset of condensation”; Cs-1 ) maximum compressional modulus; Am ) area at which Cs-1 was attained.
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measured dynamically, at a frequency that can prevent film
accommodation. The most important conclusion from this first
work arose from the combination of surface pressure and surface
potential measurements. As the maximum signals at the end of
the compression for both measurements were almost the same
with or without chitosan in the subphase (for both lipids), a
model was constructed for the interaction. It was supposed that
chitosan, which presented surface activity induced by the
interfacial film of phospholipid, could adsorb and penetrate in
the film modulating its properties. However, for higher states
of packing of the membrane, it was assumed that chitosan was
expelled from the interface, being located at the subsurface of
the monolayer (see ref 62 Figure 8 and its discussions).
In a subsequent work, the phospholipid dimyristoyl phos-
phatidic acid (DMPA) was used for taking advantage of the
easiness in transferring multiple layers of DMPA onto solid
supports as LB films.63 In the latter paper and in all other
subsequent works from our group, the chitosan sample used
had a Mn of 113 kDa and DA ) 22%. For Langmuir films of
DMPA approximately the same trend of effects found for DPPC
and DPPG was observed with the addition of chitosan to the
subphase, that is, expansion of the film and decrease in the
surface compressional modulus. However, in this case the
dynamic surface elasticity also decreased with the addition of
chitosan, which was attributed to the strong electrostatic binding
between the materials. This hinders sudden conformation
changes in phospholipid packing and chain orientation when
the surface goes through a mechanical deformation. In addition,
the higher surface potential signal observed for the compact
film in the presence of chitosan led us to infer that chitosan
was not expelled from the interface in this system.
With the help of LB film characterization, we confirmed the
hypothesis that chitosan was not expelled. The transfer of about
150 ng of chitosan along with about 110 ng of DMPA for each
layer in an 11-layer LB film was measured through QCM
nanogravimetry. The presence of chitosan in the LB film was
confirmed by FTIR measurements. The AFM images of chito-
san-containing LB films displayed large patches with height
between 50 and 150 nm, resembling the patches reported by
Parra-Barraza et al. for LB films of cholesterol.60 An increase
in the film roughness (rms) from 0.26 to 25.8 nm was caused
by the presence of 0.200 mg/mL of chitosan in the subphase of
the precursor Langmuir film. Even when the large patches were
excluded from the calculations, the rms value (3.16 nm) was 1
order of magnitude higher than that for the pure DMPA LB
film. Therefore, chitosan was present both in large aggregates
and as subsurface for the DMPA monolayer.
A more complex model for the membrane was studied that
involved mixed films of cholesterol and phospholipids, and using
additional, sophisticated surface characterization techniques,
namely, PM-IRRAS (polarization modulated infrared reflection
absorption spectroscopy) and SFG (sum-frequency generation
spectroscopy).64 The surface pressure and surface potential
isotherms were not altered when the proportion of cholesterol
and DMPA in the Langmuir film was varied, provided that the
subphase contained chitosan. This unexpected result means that
replacing cholesterol by DMPA molecules did not change the
isotherms. The explanation was based on the driving force for
the chitosan action, believed to arise from the electrostatic
interaction between NH3+ groups from chitosan and DMPA.
Because such interaction occurs in a restricted number of sites,
not all DMPA molecules interact with chitosan. Those that
remain surface inert can be replaced by cholesterol molecules
without affecting the isotherms significantly because the cho-
lesterol molecules occupy the area left by DMPA. In spite of
this inert role, Pavinatto et al. concluded that cholesterol
modulated the chitosan penetration and its effect on the
ionization of DMPA head groups.
The effects from chitosan on DMPA/cholesterol monolayers
also included an increased order of the DMPA chains, which
was inferred from the appearance of a peak at 2883 cm-1 in
the PM-IRRAS spectrum. The chain alignment was preserved
in deposited LB films, according to SFG measurements, where
the order parameter of the mixed film increased with incorpora-
tion of chitosan.64 Other effects from chitosan which could be
identified with the PM-IRRAS measurements were the slight
change in orientation of the phosphate groups in DMPA and
the change in the extent of chitosan incorporation in the
monolayer. The amount of chitosan at the interface increased
up to a pressure of 15 mN/m, which points to penetration into
the region of the alkyl tails of DMPA. From the observations
above, the authors proposed a model for the interaction of
chitosan with DMPA/cholesterol monolayers, which comprises
two steps: (i) first, chitosan migrates from the subphase to the
interface and interacts with the mixed monolayer, especially
via electrostatic forces between its protonated amine groups and
the negatively charged phosphate groups of DMPA; (ii) then
chitosan penetrates and expands the monolayer, also causing
the DMPA hydrophobic tail to be more oriented.
The initial studies and the available literature pointed to the
electrostatic interactions between amine groups of chitosan and
phosphate moieties in the phospholipid headgroups as the
driving force for the interaction.65 However, from a comparison
with the effects of an analogous polyelectrolyte (polyallylamine:
PAH), we could observe that the global effects from chitosan
are also due to additional contributions from other intrinsic
parameters of the polymer. Such parameters are believed to be
mainly specific chain conformations adopted by chitosan in
solution (e.g., rod-like, random-coil, helix, etc.) and synergistic
effects from hydroxyl groups and from the polysaccharide
backbone.65
A promising, almost unexplored, application of chitosan was
investigated in ref 66 in which chitosan was able to remove a
protein, -lactoglobulin (BLG), from negatively charged phos-
pholipid monolayers. This was inspired in the work by Casal
et al.67 who showed that chitosan could sequester BLG from
milk. In the experiments with Langmuir films, Caseli et al.
showed that BLG could be incorporated into DMPA monolayers
at the air-water interface, but BLG was removed when chitosan
was injected after the saturation of BLG adsorption. This effect
on the adsorption kinetics is illustrated in Figure 7, which
features a final pressure that is about 2 mN/m smaller than the
initial pressure, and indicates that some DMPA molecules were
removed from the monolayer together with BLG. A model for
this phenomenon is shown in Figure 8. This action of chitosan
is specific for membranes made with negatively charged
phospholipids and for the protein BLG. Such specificity
indicated again that chitosan activity is associated with its
protonated amino groups and interaction with negatively charged
groups.
3.2. Chitosan-Containing LbL Films. Chitosan, being
positively charged at low pHs, can be attached electrostatically
to negatively charged compounds, including polymers, carbon
nanotubes, and inorganic complexes. The electrostatic LbL
approach to produce nanostructured films suggested by Decher
et al.22 is based on the deposition of alternating layers of
positively and negatively charged species. Usually the thickness
per layer depends on the physical conditions of deposition and
Chitosan in Nanostructured Thin Films Biomacromolecules, Vol. 11, No. 8, 2010 1903
on the nature of the material. In many cases, monomolecular
layers can be produced.
Chitosan has been deposited in LbL films for more than a
decade,68 serving as matrix to build devices with tailored
properties for a variety of purposes, including sensing, drug and
gene delivery, anticoagulant devices, osseous implant, and
healing. Some of the applications of chitosan-containing LbL
films are reported as follows.
3.2.1. Matrix for ActiVe Elements in Sensors. Chitosan can
be coimmobilized with several substances on solid supports for
sensors, normally biomolecules with molecular recognition
properties, including enzymes, antigens, and parts of nucleic
acids. Electrochemical sensors can have their performance
improved by enhancing the electron transport with incorporation
of carbon nanotubes, phthalocyanines, and porphyrins, whose
adsorption may be facilitated with a chitosan matrix.
3.2.1.1. Sensors with Enzymes. Chitosan has been the matrix
for several enzymes using various techniques,13 with the enzyme
activity being preserved,69 probably owing to its biocompat-
ibility. Sensors have been produced to identify wines, sugar,
and fish and to detect organic compounds in waste waters, in
addition to sophisticated biosensors for in situ measurements
of environmental pollutants and metabolite control in artificial
organs. Table 3 provides a list of enzymes immobilized in
chitosan matrices. The most popular enzyme is glucose oxidase,
while the most common method for analyte determination is
electrochemistry, with analysis of the electric current generated
during the oxidation of glucose into hydrogen peroxide and
gluconic acid.
Optical methods have also been employed, as in the deter-
mination of paraoxon,69 an organophosphate compound that is
an acetylcholinesterase inhibitor used as an active metabolite
of the insecticide parathion. Proteins with heme groups attached,
such as hemoglobin and myoglobin, are used due to the
specificity of the heme chemical group, able to transport oxygen,
and serve as a catalyst of hydrogen peroxide.
In sensors based on electrochemical measurements, using
chitosan as a matrix may be disadvantageous because chitosan
may hamper the flux of electrons between the analyte aqueous
solution and the electrode. For instance, successive layers of
chitosan/glucose oxidase may not necessarily increase the
current signal because only the enzyme at the uppermost layer
seems to be active.92 Therefore, optimized conditions must be
sought for enhancing sensing performance.
3.2.1.2. Sensors with Antigens and Parts of Nucleic Acids.
There have also been cases where the molecular recognition
capability of the biosensor involves interaction with other
biomolecules. For instance, DNA has been adsorbed with
chitosan for detecting oligonucleosides electrochemically.93,94
In another study,95 Escherichia coli cells were encapsulated with
LbL films of chitosan and a polyanion (alginate, hyaluronic acid,
or a oligonucleoside). This system was then used as a biorec-
ognition system, which is useful for gene therapy. Furthermore,
chitosan intercalated with DNA was fabricated to enhance the
voltammetric signal of uric acid, with high selectivity to ascorbic
acid.96 Antigen-antibody systems have been used for fabrication
of immunosensors, with chitosan layers alternated with a
negatively charged polysaccharide (alginate) being used to
immobilize an antigen on the uppermost layer.97 The combina-
tion of glassy carbon, chitosan, gold nanoparticles, and carci-
noembryonic antibody produced a bioinspired system with
enhanced electrochemical properties, producing therefore an
immunosensor with high sensitivity, selectivity, and stability.98
3.2.1.3. Sensors with Compounds that Enhance the
Electric Signal. These sensing systems are based on the
specificity of the enzyme by its catalytic substrate, but sensors
have been constructed when the electrode is modified with
chitosan-based LbL films to enhance the electric signal. In this
case, chitosan-based LbL films can be seen as a new hybrid
material protecting the electrode. One of the most popular
strategies is the use of carbon nanotubes99 combined with
chitosan, used for increasing the oxidation current in detecting
dopamine,100 NADH (nicotinamide adenine dinucleotide),101
DNA (deoxyribonucleic acid) damaging (with DNA interaction
with chitosan and carbon nanotubes layers),94 glucose (with
Prussian blue as mediator),102 and hydrogen peroxide.103 In the
latter case, chitosan and carbon nanotubes were immobilized
in an LbL fashion on gold nanoparticles, with cytochrome C
immobilized on the uppermost layer. This example shows how
the fabrication of hybrid materials with chitosan, in a variety
of architectures, has provided materials with tailored properties.
Also, Fe3O4 nanoparticles were coimmobilized with chitosan
to enhance the electrode conductivity,104 analogous to the use
of dyes to enhance the optical signal for ethanol sensing.105 LbL
films of metal-phthalocyanines alternated with chitosan have
been used to detect dopamine with low interference, where the
electrochemical properties were enhanced due to optimization
of the electron transfer through the film.106
3.2.1.4. Other Kinds of Sensors. Chitosan-alginate LbL films
were deposited on a gold support and made to interact with
Figure 7. Kinetics of BLG adsorption onto a DMPA Langmuir
monolayer in the presence of chitosan. Three events can be
recognized: (i) BLG adsorption; (ii) chitosan incorporation and
material removal from the interface; and (iii) stabilization. BLG and
chitosan concentration were 0.25 mg/mL and 0.20 mg/mL, respec-
tively. Reproduced from ref 66. Copyright 2008 American Chemical
Society.
Figure 8. Model for the BLG removal from a DMPA Langmuir
monolayer caused by chitosan. Reproduced from ref 66. Copyright
2008 American Chemical Society.
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Pseudomonas aeruginosa cells, which were detected optically
by the change in refractive index of substrate + film.107
Chitosan simply deposited in a layer-film on silicate was used
to remove heavy metals from water such as Cd(III), Cr(III),
and Cr(IV),108 due to its good sorption capacity, and to detect
Cu(II) with impedance spectroscopy.109 LbL films containing
chitosan and synthetic polymers were used in taste sensors
for beverages.110,111
3.2.2. LbL Films with Chitosan for Membranes and for
ImproVing Physical and Biological Properties of Materials. In
most applications for sensing with LbL films, as discussed in
the last subsection, chitosan was used merely as a matrix to
help preserve the activity of a biomolecule, being therefore
relatively inert. The mechanical and biocompatibility of chitosan
are, however, exploited in membranes and other materials. Being
the only positively charged polysaccharide in nature, it can be
combined with negatively charged or neutral materials, espe-
cially those of biological interest, including heparin, cellulose,
hyaluronan, and dextran sulfate, for various applications. These
include adsorption of proteins,112-118 increase in mechanical
resistance,119-123 cytotoxicity, and protection against wound
infections, enhancement of electrical conductivity,110,111,124-126
changes in optical and electrochromic properties,127-134 and use
of fluorescence probes.135
For many nanocomposites made from chitosan, it is a
challenge to obtain good mechanical properties because
chitosan is sensitive to humidity. To obviate this limitation,
researchers136-138 have described the reinforcement of chi-
tosan by nanofillers in LbL films to increase their mechanical
strength. For instance, Darder et al.139 intercalated chitosan
with Na-montmorilonite, providing robust nanocomposites
used in bulk-modified electrodes with easy surface renewal,
ruggedness, and long-term stability. Wang et al.140 prepared
chitosan/carbon nanotube composites with the solution
evaporation method, in which the nanotubes were homoge-
neously dispersed throughout the chitosan matrix. The
mechanical properties (tensile modulus and strength of the
nanocomposites) were greatly improved with incorporation
of nanotubes into the chitosan matrix. LbL films from
deacetylated chitosan and eucalyptus wood cellulose nano-
whiskers (CNWs) were formed with hydrogen bonding and
electrostatic interactions between the negatively charged
sulfate groups on the whisker and the positively groups of
chitosan.141 These biodegradable nanocomposites are also
expected to have enhanced mechanical and thermal properties.
Of particular importance is the interaction of chitosan with
hyaluronan. Both are biocompatible materials and have been
used in membranes. Saloma¨ki et al.120 reported the enhanced
viscoelastic properties of chitosan/hyaluronan LbL films, which
displayed higher mechanical strength. Chitosan-alginate was
used for other purposes, as for tissue engineering in attaching
hepatic cells,32 where the biocompatibility of the polysaccharide-
based adsorption matrix was explored. The resistance of chitosan
against external factors is also useful, for example, in preventing
enzyme degradation,141-146 coagulation,147 and microorganism
attack.87,148-150
Biomaterials that use LbL films with chitosan are also
important. For instance, chitosan coimmobilized with heparin
in several layers have been used to tailor the properties of
coronary stent in terms of anticoagulation for clinic use.146 The
chitosan/heparin system was reported as antiadhesive and
bactericide, forming a biomacromolecular self-assembly that is
safe and efficient in promoting the re-endothelialization and
healing after stent implantation. The LbL technique was
suggested to be easy to apply to the surface of drug healing
stent systems. The combination of polysaccharide LbL films
with cell adhesive peptides may enhance orthopedic implant
properties, replacing Ti and its alloys, thus, avoiding bacterial
infection.87 Also worth mentioning is the combination of
materials to seek synergy in their properties, as gold nanopar-
ticles, poly(L-lactic acid), chitosan, and dextran sulfate.150 The
metal nanoparticles usually have bactericide properties that can
be combined with polysaccharides to enhance their character-
istics of hydrophobicity, hemocompatibility, cytocompatibility,
and antibacterial activity against Methicilin-resistant Staphylo-
coccus aureus.
Actuators have been produced with chitosan LbL films in
surface acoustic impedance,151 robotic rapid systems,152 and
electroactive paper actuators.153 Chitosan coimmobilized with
poly(vinyl-sufonic acid) and H2PtCl6 on platinum plates can also
be applied as a catalyst layer for proton exchange membrane in
direct methanol fuel cells.154
Table 3. Enzymes and Heme-Proteins Immobilized on Chitosan Matrix with the LbL Technique for Sensing
enzyme/protein analyte method of detection ref
glucose oxidase glucose optical 70
urease + superoxide dismutase urea electrochemical 71
glucose oxidase glucose electrochemical 72
glucose oxidase glucose optical 73
pectinase pectin optical 74
hemoglobine hydrogen peroxide electrochemical 75
glucose oxidase glucose electrochemical 76
glucose oxidase glucose electrochemical 77
glucose oxidase glucose electrochemical 78
glucose oxidase glucose electrochemical 79
glucose oxidase glucose electrochemical 80
tyrosinase neurotransmitter metabolite electrochemical 81
polyphenol oxidase catechol and phenol electrochemical 82
organophosphorus hydrolase paraoxon optical 69
organophosphorus hydrolase paraoxon optical 83
horseradish peroxidase and myoglobin hydrogen peroxide electrochemical 84
myoglobin hydrogen peroxide and trichloroacetic acid electrochemical 85
myoglobin hydrogen peroxide and trichloroacetic acid electrochemical 86
hemoglobin hydrogen peroxide electrochemical 87
horseradish peroxidase hydrogen peroxide electrochemical 88
pectinase polygalacturonic acid optical 89
glucose oxidase glucose optical 90
horseradish peroxidase hydrogen peroxide optical 91
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3.2.3. Chitosan Vehicles for Drug DeliVery and Other
Applications. LbL films with chitosan have been reported for
protein and drug encapsulation for controlled release,102,155-166
including gene delivery167 and encapsulation of lipid capsules
and liposomes.168 The encapsulation of these materials imparts
a higher resistance and biocompatibility with more durable drug
delivery systems. Chitosan/alginate structures, for instance, are
able to encapsulate enzymes and drugs for release, with a
decrease in the drug bioactivity, but with enhanced storage
stability.71 Grech et al. produced beads with chitosan and
hyaluronic acid for controlled release of gentamicin sulfate
(antibiotic to treat bacterial infection and osteomyelitis), produc-
ing biodegradable microspheres (beads) that do not require
surgical removal from the body.169 In this case, the release
depends on the permeability and on the breakdown of the
multilayer structures. The drug release has also been prolonged
when ibuprofen was encapsulated with chitosan/alginate mi-
crocapsules produced by the LbL technique, with reduction of
the initial burst related to the drug delivery.165
The covering of liposomes and lipid emulsion by chitosan-
negative polysaccharide LbL films has been reported to improve
liposome stability which may control the delivery of encapsu-
lated proteins and drugs.168,170-173 For instance, lecithin and
chitosan LbL films encapsulating lipid droplets (emulsion) have
been used to prove that chitosan does not inhibit in vitro
digestibility, which may have important implications for the
possible chitosan activity as a fat reducer agent in food
ingestion.170 Lecithin and chitosan encapsulating oil droplets
have also been used as food additive.174,175
4. Concluding Remarks and Perspectives
The extensive use of chitosan in a variety of applications is
reflected in a large number of papers published. By way of
illustration, a search on the ISI Web of Science with the keyword
“chitosan” leads to almost 17000 entries in May, 2010. Most
of the applications are related to its biological properties,
including antimicrobial activity, wound healing ability, and
ability to encapsulate biomolecules for drug delivery. In spite
of the prolific scientific production in the field, little is known
about the molecular mechanisms responsible for the biological
activity of chitosan. It is precisely within this context that the
nanostructured films may be exploited, which was also the main
motivation for us to produce this review.
Using Langmuir monolayers and LB films is essential to
understanding some of the molecular-level mechanisms, espe-
cially those associated with the interaction with cell membranes.
The recent findings with cell membrane models have allowed
one to infer that electrostatic interactions may be the most
important feature in the action, but they are not the only one.
Further studies are now required to elucidate this point, which
should include the following as major topics: (i) use of chitosan
derivatives, especially those with surface-active properties that
may lead to the formation of Langmuir monolayers on their
own; (ii) combination of various biomolecules in Langmuir
monolayers in order to achieve a more realistic cell membrane
model, as has been done with mixtures of cholesterol and
phospholipids64 and with proteins;66 and (iii) attempts to identify
the sites of interaction between chitosan and the lipids. It is
likely that sophisticated experimental methods will be required
to study such interactions, and here emphasis should be placed
on the already mentioned spectroscopic techniques PM-IRRAS
and SFG. The ultimate understanding of the molecular-level
interactions will also depend on the capability of researchers in
the field in theoretical modeling. The first attempts in this regard
involved molecular dynamics simulations,176 but the results are
only modest in terms of possible interactions with membrane
models or other biomolecules. The sheer size of chitosan
molecules and the intricate possibilities of conformation prevent
any accurate modeling. For this very reason we shall have to
wait a considerable time for realistic simulations to be carried
out with quantum mechanical methods.
Though limited in the quantification of the interactions, as
mentioned above, molecular modeling and the investigation of
molecular-level interactions with experimental techniques may
help in predicting chitosan properties with practical implications.
For example, it may be possible to determine the chemical
modifications to be made in the chitosan for optimizing its
bioactivity in specific cases, in addition to obtaining the ideal
dosage in medical applications to reduce side effects.
Equally important for nanostructured films of chitosan are
the applications exploiting the control of molecular architecture
of these films. As discussed in this review, chitosan films have
been used in various types of biosensors, particularly because
chitosan has been proven to be excellent scaffolding material
to preserve the activity of biomolecules. Two additional
applications are for drug delivery in patches made with chitosan
films and surface modification for cell growth aimed at tissue
engineering. In conclusion, the abundant evidence for the action
of chitosan in nanostructured films holds the promise for real
applications to be made over the next few years.
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